SCHEMBL7605746

SCHEMBL7605746

Cc1cc(-n2c3ccccc3c3ccccc32)ccc1-c1c2ccccc2c(-c2ccccc2)c2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ATM Q13315 1/20 0.44
KMT2A Q03164 3/20 0.38
POLB P06746 1/20 0.36
ESR2 Q92731 1/20 0.36
HSD17B10 Q99714 1/20 0.35
LMNA P02545 3/20 0.33
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ACHE P22303 1/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
MYC P01106 1/20 0.33
HDAC4 P56524 1/20 0.33
RCE1 Q9Y256 1/20 0.33
IL1R1 P14778 1/20 0.33
TSHR P16473 1/20 0.32
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6114023 0.89 MAOA (0.39) KDM4EL3MBTL1ATMACHEMAPT
SCHEMBL7600811 0.88 KDM4E (0.44) KDM4EL3MBTL1ATMKMT2APOLB
SCHEMBL21037876 0.88 L3MBTL1 (0.50) KDM4EL3MBTL1ATMKMT2APOLB
SCHEMBL12103564 0.86 L3MBTL1 (0.42) KDM4EL3MBTL1ATMKMT2APOLB
SCHEMBL7602347 0.86 KDM4E (0.42) KDM4EL3MBTL1ATMKMT2ALMNA
SCHEMBL10100810 0.84 KDM4E (0.46) KDM4EL3MBTL1ATMKMT2APOLB
SCHEMBL63587 0.84 KDM4E (0.52) KDM4EL3MBTL1ATMKMT2APOLB
SCHEMBL29462706 0.84 KDM4E (0.52) KDM4EL3MBTL1ATMKMT2APOLB
SCHEMBL29349946 0.84 KDM4E (0.52) KDM4EL3MBTL1ATMKMT2APOLB
SCHEMBL15835159 0.84 DHODH (0.37) KDM4EKMT2AMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8845926-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-8518492-B2 Composition, method for manufacturing thin film, and method for manufacturing light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-08-27 US disclosed
US-20130005067-A1 Anthracene Derivative, Material For Light Emitting Element, Light Emitting Element, Light Emitting Device, And Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-01-03 US disclosed
US-20130005067-A1 Anthracene Derivative, Material For Light Emitting Element, Light Emitting Element, Light Emitting Device, And Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-01-03 US disclosed
US-20120288620-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-11-15 US disclosed
US-20120288620-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-11-15 US disclosed
US-8298687-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-30 US disclosed
US-8298687-B2 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-10-30 US disclosed
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2011-03-03 US disclosed
US-20090317539-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-12-24 US disclosed
US-20090317539-A1 Composition, Method for Manufacturing Thin Film, and Method for Manufacturing Light-Emitting Element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-12-24 US disclosed
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-01-15 US disclosed
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2009-01-15 US disclosed
US-20080286445-A1 COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-20080286445-A1 COMPOSITION, AND METHOD OF FABRICATING LIGHT-EMITTING ELEMENT SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-11-20 US disclosed
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-05-08 US disclosed
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-05-08 US disclosed
WO-2008026614-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110050118-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 KDM4E 2175/4885L3MBTL1 3456/4885ATM 527/4885
US-20080107918-A1 METHOD FOR SYNTHESIZING ANTHRACENE DERIVATIVE AND ANTHRACENE DERIVATIVE, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, ELECTRONIC DEVICE ALAD, CYP2C9, CYP1A1 KDM4E 2175/4885L3MBTL1 3456/4885ATM 527/4885
US-20090015140-A1 Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device CRY1, CRY2, CYBA KDM4E 2566/4885L3MBTL1 3184/4885ATM 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.